{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:24:49Z","timestamp":1791401089158,"version":"4.3.3"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010590","name":"Tianjin Municipal Health Bureau","doi-asserted-by":"publisher","award":["13KG118"],"award-info":[{"award-number":["13KG118"]}],"id":[{"id":"10.13039\/501100010590","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.jad.2019.07.045","type":"journal-article","created":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T19:21:15Z","timestamp":1562354475000},"page":"640-649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":137,"special_numbering":"C","title":["Inflammatory markers and treatment outcome in treatment resistant depression: A systematic review"],"prefix":"10.1016","volume":"257","author":[{"given":"Chenghao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaas J.","family":"Wardenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fokko J.","family":"Bosker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Schoevers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2019.07.045_bib0001","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jpsychires.2018.02.011","article-title":"Kynurenine pathway metabolism and the neurobiology of treatment-resistant depression: comparison of multiple ketamine infusions and electroconvulsive therapy","volume":"100","author":"Allen","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2019.07.045_bib0002","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.physbeh.2019.05.006","article-title":"The efficacy of anti-inflammatory treatment interventions on depression in individuals with major depressive disorder and high levels of inflammation: a systematic review of randomized clinical trials","volume":"207","author":"Allison","year":"2019","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.jad.2019.07.045_bib0003","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jad.2006.12.015","article-title":"Sensitivity to change, discriminative performance, and cutoff criteria to define remission for embedded short scales of the Hamilton depression rating scale (HAMD)","volume":"102","author":"Ballesteros","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2019.07.045_bib0004","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.psyneuen.2018.09.004","article-title":"Glucose and lipid-related biomarkers and the antidepressant response to infliximab in patients with treatment-resistant depression","volume":"98","author":"Bekhbat","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jad.2019.07.045_bib0005","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1038\/sj.npp.1301606","article-title":"Intrahippocampal transplantation of transgenic neural precursor cells overexpressing interleukin-1 receptor antagonist blocks chronic isolation-induced impairment in memory and neurogenesis","volume":"33","author":"Ben Menachem-Zidon","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2019.07.045_bib0006","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/(SICI)1520-6394(1997)5:4<154::AID-DA2>3.0.CO;2-D","article-title":"Treatment-refractory depression: definitions and characteristics","volume":"5","author":"Berman","year":"1997","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jad.2019.07.045_bib0007","doi-asserted-by":"crossref","first-page":"e488","DOI":"10.1038\/tp.2014.129","article-title":"Inflammation and lithium: clues to mechanisms contributing to suicide-linked traits","volume":"4","author":"Beurel","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2019.07.045_bib0008","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bbi.2010.10.008","article-title":"Immune suppression and immune activation in depression","volume":"25","author":"Blume","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2019.07.045_bib0009","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.bbi.2016.08.002","article-title":"Age and sex differences in immune response following LPS treatment in mice","volume":"58","author":"Cai","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2019.07.045_bib0010","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s13311-017-0537-8","article-title":"Vagal nerve stimulation for treatment-resistant depression","volume":"14","author":"Carreno","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jad.2019.07.045_bib0011","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jad.2012.10.036","article-title":"Lack of clinical therapeutic benefit of antidepressants is associated overall activation of the inflammatory system","volume":"148","author":"Carvalho","year":"2013","journal-title":"J. Affect. Disord."},{"issue":"38 Suppl","key":"10.1016\/j.jad.2019.07.045_bib0012","first-page":"S167","article-title":"Bipolar disorders and somatic comorbidities: a focus on metabollic syndrome, diabetes and cardiovascular disease","volume":"4","author":"Chauvet-Gelinier","year":"2012","journal-title":"L'Encephale"},{"key":"10.1016\/j.jad.2019.07.045_bib0013","first-page":"207","article-title":"Rapid inflammation modulation and antidepressant efficacy of a low-dose ketamine infusion in treatment-resistant depression: a randomized, double-blind control study","volume":"269","author":"Chen","year":"2018","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2019.07.045_bib0014","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.neuropharm.2016.04.021","article-title":"Ketamine modulates hippocampal neurogenesis and pro-inflammatory cytokines but not stressor induced neurochemical changes","volume":"112","author":"Clarke","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jad.2019.07.045_bib0015","series-title":"Rating Scale for Depression","author":"Cusin","year":"2010"},{"key":"10.1016\/j.jad.2019.07.045_bib0016","doi-asserted-by":"crossref","first-page":"688","DOI":"10.4088\/JCP.v67n0501","article-title":"Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression","volume":"67","author":"Dunner","year":"2006","journal-title":"J. Clin. Psychiatry."},{"key":"10.1016\/j.jad.2019.07.045_bib0017","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.pnpbp.2007.09.015","article-title":"Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder","volume":"32","author":"Eller","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2019.07.045_bib0018","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0193-953X(05)70283-5","article-title":"Definition and epidemiology of treatment-resistant depression","volume":"19","author":"Fava","year":"1996","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.jad.2019.07.045_bib0019","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neuroscience.2013.04.060","article-title":"Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications","volume":"246","author":"Felger","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.jad.2019.07.045_bib0020","first-page":"662","article-title":"Mental illness and public health: exploring the role of general hospital physicians at a teaching hospital in Jamaica","volume":"59","author":"Gibson","year":"2010","journal-title":"West Indian Med. J."},{"key":"10.1016\/j.jad.2019.07.045_bib0021","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/mp.2016.3","article-title":"A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression","volume":"21","author":"Goldsmith","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2019.07.045_bib0022","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.psyneuen.2007.09.004","article-title":"A dual role for interleukin-1 in hippocampal-dependent memory processes","volume":"32","author":"Goshen","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jad.2019.07.045_bib0023","doi-asserted-by":"crossref","first-page":"e436","DOI":"10.4088\/JCP.14m09577","article-title":"Prediction of nonremission to antidepressant therapy using diffusion tensor imaging","volume":"77","author":"Grieve","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2019.07.045_bib0024","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1055\/s-0028-1094412","article-title":"Therapy-resistant depressions: symptoms and syndromes. Contributions to symptomatology and syndromes.","volume":"7","author":"Heimann","year":"1974","journal-title":"Pharmakopsychiatr. Neuropsychopharmakol."},{"key":"10.1016\/j.jad.2019.07.045_bib0025","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.bbi.2012.06.001","article-title":"A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: exploring the causes of heterogeneity","volume":"26","author":"Hiles","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2019.07.045_bib0026","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis","volume":"71","author":"Howren","year":"2009","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.jad.2019.07.045_bib0027","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000484665","article-title":"Both serum brain-derived neurotrophic factor and Interleukin-6 levels are not associated with therapeutic response to lamotrigine augmentation therapy in treatment-resistant depressive disorder","volume":"75","author":"Kagawa","year":"2017","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.jad.2019.07.045_bib0028","doi-asserted-by":"crossref","first-page":"9117","DOI":"10.1073\/pnas.89.19.9117","article-title":"Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1","volume":"89","author":"Kent","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jad.2019.07.045_bib0029","doi-asserted-by":"crossref","first-page":"e1065","DOI":"10.1038\/tp.2017.31","article-title":"Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome","volume":"7","author":"Kiraly","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2019.07.045_bib0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/trstmh\/tru167","article-title":"Sex-based differences in immune function and responses to vaccination","volume":"109","author":"Klein","year":"2015","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.jad.2019.07.045_bib0031","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1055\/s-0043-118667","article-title":"Relationship between oxidative stress, inflammation and dyslipidemia with fatty liver index in patients with type 2 diabetes mellitus","volume":"126","author":"Klisic","year":"2018","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.jad.2019.07.045_bib0032","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/15622975.2017.1355473","article-title":"Antidepressant efficacy of electroconvulsive therapy is associated with a reduction of the innate cellular immune activity in the cerebrospinal fluid in patients with depression","volume":"19","author":"Kranaster","year":"2018","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2019.07.045_bib0033","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1001\/archneur.1985.04060040016004","article-title":"Multiple sclerosis and depression","volume":"42","author":"Kronfol","year":"1985","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jad.2019.07.045_bib0034","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0165-0327(85)90097-7","article-title":"Depression, cortisol metabolism and lymphocytopenia","volume":"9","author":"Kronfol","year":"1985","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2019.07.045_bib0035","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17m11597","article-title":"Inflammation and improvement of depression following electroconvulsive therapy in treatment-resistant depression","volume":"79","author":"Kruse","year":"2018","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2019.07.045_bib0036","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0893-133X(99)00134-7","article-title":"Cytokine production and treatment response in major depressive disorder","volume":"22","author":"Lanquillon","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2019.07.045_bib0037","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1055\/s-0028-1094425","article-title":"Therapy-resistant depressions - a clinical classification","volume":"7","author":"Lehmann","year":"1974","journal-title":"Pharmakopsychiatr. Neuropsychopharmakol."},{"key":"10.1016\/j.jad.2019.07.045_bib0038","first-page":"139","article-title":"Effects of ketamine on levels of inflammatory cytokines IL-6, IL-1beta, and TNF-alpha in the hippocampus of mice following acute or chronic administration","volume":"8","author":"Li","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jad.2019.07.045_bib0039","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jad.2018.04.115","article-title":"Different levels of pro- and anti-inflammatory cytokines in patients with unipolar and bipolar depression","volume":"237","author":"Mao","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2019.07.045_bib0040","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.clim.2005.08.004","article-title":"C-reactive protein: ligands, receptors and role in inflammation","volume":"117","author":"Marnell","year":"2005","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jad.2019.07.045_bib0041","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1503\/cmaj.050786","article-title":"Measuring the severity of depression and remission in primary care: validation of the HAMD-7 scale","volume":"173","author":"McIntyre","year":"2005","journal-title":"CMAJ"},{"key":"10.1016\/j.jad.2019.07.045_bib0042","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression","volume":"65","author":"Miller","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2019.07.045_bib0043","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jpsychires.2006.05.008","article-title":"The burden of severe depression: a review of diagnostic challenges and treatment alternatives","volume":"41","author":"Nemeroff","year":"2007","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2019.07.045_bib0044","doi-asserted-by":"crossref","first-page":"855","DOI":"10.4088\/JCP.13m08947","article-title":"Effect of adjunctive L-methylfolate 15 mg among inadequate responders to SSRIs in depressed patients who were stratified by biomarker levels and genotype: results from a randomized clinical trial","volume":"75","author":"Papakostas","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2019.07.045_bib0045","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.biopha.2017.09.014","article-title":"\"2-(4-Fluorobenzamido)-4-methylthiazole-5-carboxylic acid\" a novel thiazole compound, ameliorates insulin sensitivity and hyperlipidaemia in streptozotocin-induced diabetic rats: plausible role of inflammatory and oxidative stress markers","volume":"95","author":"Paudel","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jad.2019.07.045_bib0046","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/0091-3057(93)90202-5","article-title":"Centrally administered bacterial lipopolysaccharide depresses feeding in rats","volume":"46","author":"Plata-Salaman","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jad.2019.07.045_bib0047","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11906-018-0842-6","article-title":"Anti-Inflammatory effects of melatonin in obesity and hypertension","volume":"20","author":"Prado","year":"2018","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.jad.2019.07.045_bib0048","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.bbi.2007.05.005","article-title":"Brain-immune communication pathways","volume":"21","author":"Quan","year":"2007","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2019.07.045_bib0049","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","article-title":"A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers","volume":"70","author":"Raison","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2019.07.045_bib0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pnpbp.2014.01.013","article-title":"Inflamed moods: a review of the interactions between inflammation and mood disorders","volume":"53","author":"Rosenblat","year":"2014","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2019.07.045_bib0051","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jns.2007.01.033","article-title":"Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders","volume":"257","author":"Sas","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jad.2019.07.045_bib0052","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1192\/bjp.183.2.92","article-title":"Global burden of depression: the intersection of culture and medicine","volume":"183","author":"Scott","year":"2003","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2019.07.045_bib0053","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.euroneuro.2007.06.004","article-title":"A detailed examination of cytokine abnormalities in major depressive disorder","volume":"18","author":"Simon","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2019.07.045_bib0054","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.neuro.2009.03.004","article-title":"The effect of tumor necrosis factor antagonists on mood and mental health-associated quality of life: novel hypothesis-driven treatments for bipolar depression?","volume":"30","author":"Soczynska","year":"2009","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.jad.2019.07.045_bib0055","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.euroneuro.2015.06.007","article-title":"Inflammation and clinical response to treatment in depression: a meta-analysis","volume":"25","author":"Strawbridge","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2019.07.045_bib0056","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.1038\/tp.2012.120","article-title":"Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes","volume":"2","author":"Sukoff Rizzo","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2019.07.045_bib0057","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/wps.20458","article-title":"Sedentary behavior and physical activity levels in people with schizophrenia, bipolar disorder and major depressive disorder: a global systematic review and meta-analysis","volume":"16","author":"Vancampfort","year":"2017","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jad.2019.07.045_bib0058","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bbi.2016.05.006","article-title":"Effect of recombinant erythropoietin on inflammatory markers in patients with affective disorders: a randomised controlled study","volume":"57","author":"Vinberg","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2019.07.045_bib0059","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bbi.2016.08.012","article-title":"Association of inflammation with specific symptoms of depression in a general population of older people: the English Longitudinal Study of Ageing","volume":"61","author":"White","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2019.07.045_bib0060","unstructured":"WHO, 2017. Depression, p.http:\/\/www.who.int\/mediacentre\/factsheets\/fs369\/en\/."},{"key":"10.1016\/j.jad.2019.07.045_bib0061","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1111\/j.1471-4159.2007.04987.x","article-title":"Treadmill exercise counteracts the suppressive effects of peripheral lipopolysaccharide on hippocampal neurogenesis and learning and memory","volume":"103","author":"Wu","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jad.2019.07.045_bib0062","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jpsychores.2018.05.008","article-title":"Interleukin, tumor necrosis factor-alpha and C-reactive protein profiles in melancholic and non-melancholic depression: a systematic review","volume":"111","author":"Yang","year":"2018","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.jad.2019.07.045_bib0063","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.biopsych.2014.06.021","article-title":"Serum interleukin-6 is a predictive biomarker for ketamine's antidepressant effect in treatment-resistant patients with major depression","volume":"77","author":"Yang","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2019.07.045_bib0064","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0006-8993(95)01415-2","article-title":"Endotoxin produces a depressive-like episode in rats","volume":"711","author":"Yirmiya","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.jad.2019.07.045_bib0065","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.pnpbp.2009.03.020","article-title":"Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression","volume":"33","author":"Yoshimura","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032719305373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032719305373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:36:58Z","timestamp":1759023418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032719305373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":65,"alternative-id":["S0165032719305373"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2019.07.045","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammatory markers and treatment outcome in treatment resistant depression: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2019.07.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}